US 10525101
Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
granted A61KA61K38/00A61K38/1774
Quick answer
US patent 10525101 (Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Department of Veterans Affairs
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61K38/1774